Novikoff hepatoma ascites cells, grown intraperitoneally in rats, are shown to possess a high-affinity, low-capacity dexamethasone-binding protein. The receptor protein has an intracellular localization and concentration, association constant (Ka), glucocorticoid specificity and nuclear uptake in the presence of dexamethasone comparable with those of the G-protein of rat liver. During therapy of the tumour-bearing animal with cortisol, marked cyclic variations were observed in the concentration and nuclear uptake of the putative G-protein in the tumour cells; more transient variations were also observed in the Ka value of the receptor protein.
Previous studies from this laboratory (Webb & Wozney, 1968; Raab & Webb, 1969; Rizzo et al., 1971; Dorman & Webb, 1974) demonstrate the reversible inhibitory effect of the glucocorticoids on DNA synthesis and mitosis in regenerating rat liver induced by partial hepatectomy. Thus a low dose of cortisol administered 19h after operation, although suppressing the initial burst of DNA synthesis normally occurring between 20 and 30h, released DNA synthesis in a highly synchronous peak centred at 35h. Loeb et al. (1973) have demonstrated the suppression by glucocorticoids of DNA synthesis in cultured hepatoma cells derived from slow-growing rat hepatoma 5123D. A dexamethasone-binding protein has been identified in a rat hepatoma in tissue culture (HTC cells) although this particular line is insensitive to glucocorticoids (Higgins et al., 1973; Singer et al., 1973) .
The present paper describes the characteristics of the dexamethasone-binding system in the rapidly growing Novikoff hepatoma cells and the temporal changes therein, during therapy of the tumourbearing rats with glucocorticoids. This study was patterned after comparable studies (Keefer et al., 1974 (Keefer et al., ,1975 that established a correspondence between fluctuations in uridine kinase isoenzymes and the development in vivo of tumour-cell resistance to 5-azacytidine.
Materials and Methods Ascites-tumour cells
Novikoff ascites-tumour cells with a transplant generation time of 7 days were carried in the intraperitoneal cavity of 140-160g female rats of the Sprague-Dawley strain (Laboratory Supplies, Indianapolis, Ind., U.S.A.). The aspirated tumour Vol. 152 cells were washed in cold balanced-salt solution (0.13M-NaCl-5.0mM-KCl-8.OmM-MgCI2) until free of erythrocytes, before reinoculation or experimental use. The tumour line was maintained by inoculating with 2.0ml of a 1:3 (v/v) dilution of washed cells pelleted at 2000g for 5min. Since the cells used in each experiment were derived from several animals the tumour-cell suspension used for reinoculation was also derived from these animals to ensure that the tumour-cell line was representative of the cells used in each experiment.
Before assay of the glucocorticoid-receptor proteins, the washed cells were incubated at 37°C in Eagle's Minimal Essential Medium (Nutritional Biochemicals, Cleveland, Ohio, U.S.A.) fortified with 2.2g of NaHCO3, 0.1mg of streptomycin sulphate and 100000 units of penicillin G/litre, to deplete the cells of all endogenous corticosteroid. After washing in the balanced-salt solution, the cells were resuspended in 1.0vol. of homogenization buffer consisting of 50mM-Tris -HCl, pH7.8, 1.0mM-dithiothreitol, .0mM-MgCI2 and 2.0mM-CaC12.
Preparation of cytosol and nuclei
The cytosol fraction was prepared from a slurry of the ascites cells in homogenization buffer by first permitting the cells to swell for 10min at 0°C, shearing them with 25 strokes ofa tight-fitting Dounce homogenizer, then centrifuging the homogenate at 105 OOOg for 60min. The 105 OOOg supernatant or cytosol fraction was assayed immediately for glucocorticoid-binding activity. For the preparation of nuclei, 1 vol. of washed cells was resuspended in medium A (0.3 M-sucrose-2.0mM-magnesium acetate-3.OmM-CaCI2-0.5mM-dithiothreitol-0.1 % Triton X-100-10.0mM-Tris-HCl, pH8.0), then homogenized with 20 strokes in a Dounce homogenizer. After 23 dilution with 1 vol. of medium B (2.0M-sucrose-3.0mM-magnesium acetate-2.OmM-CaCI2-0.5mM-dithiothreitol-1O.OmM-Tris-HCl, pH8.0), a portion of the homogenate was layered over 3.Oml of medium B and the discontinuous gradient was centrifuged for 1 h at 34900g. The nuclei were suspended in 1.OMsucrose (complete medium B diluted 1:1 with water), then collected by centrifugation for 5min at 3020g. After suspension of the nuclei in 1.OM-sucrose, their concentration was estimated by counting in a haemocytometer. The DNA recovery was 65 % (corrected for mitochondrial DNA) based on DNA analysis of the homogenate and nuclei, or 70 %, based on the number of nuclei recovered and number of cells from which they were derived.
Steroid-binding and nuclear-uptake studies
The modified steroid-binding assay (Beato & Feigelson, 1972 ) contained 1.0-16.Opmol of labelled steroid (sp. radioactivity 17000c.p.m./pmol) with or without unlabelled steroid and lOO1ul of cytosol, in a total volume of 200jul. After incubation for 2.0h at 0°C, the protein-bound steroid was assayed by use of DEAE-ellulose filter discs (DE-81 filter; Whatman Co., Freehold, N.J., U.S.A.) presoaked for 1 h in 0.02M-Tris-HCl buffer, pH7.9 at 4°C, containing 1.5 mM-EDTA (Santi et al., 1973) . Specific binding was estimated by subtracting the non-specific binding occurring in the presence of a 500-fold excess of unlabelled dexamethasone in 15 % (v/v) ethanol. The latter was dissolved in 15 % ethanol, the concentration in the assay being less than 2%; this ethanol did not alter the steroidbinding reaction (Baxter & Tomkins, 1971 ; S. Liu, unpublished observations).
The nuclear uptake of receptor-bound labelled glucocorticoid was estimated (Kalimi et al., 1973) by incubating the unfractionated cytosol receptor proteins at 0°C for 2h in a 60nM solution of the labelled glucocorticoid. The free steroid was removed by use of dextran-coated charcoal, then the glucocorticoid-charged-cytosol was incubated for 30min at 0°C (controls), or at 20°C (experimental) with samples of the nuclei. The volume of the reaction mixture was adjusted to 1.Oml with 50mM-Tris-HCl buffer, pH7.8, containing l.OmM-dithiothreitol, L.OMM-MgCl2 and 2.OmM-CaCI2. After incubation, the nuclei were washed with 2 x 5.0ml of medium B diluted 1:1 with water, then dissolved in solubilizer before radioassay in liquid scintillant (Isolab, Akron, Ohio, U.S.A.).
Protocol for the development and assay of resistance (cf. Aronow & Gabourel, 1962) To develop resistance to glucocorticoids, rats bearing the Novikoff ascites-tumour cells received a subtherapeutic intraperitoneal dose of cortisone acetate (25mg/kg) on days 2, 4 and 6 after the intraperitoneal inoculation of the tumour cells, each transplant generation (i.e. each 7 days). Alternatively, to test for glucocorticoid resistance in any one transplant generation, the tumourbearing animals received 0.85% NaCl (controls) or 75 mg of cortisone acetate/kg on days 4, 5 and 6 after inoculation of the cells, then on day 7 cells were removed for assay of the rate of DNA synthesis. The latter parameter was measured by incubating the washed Novikoff ascites-tumour cells in Eagle's Minimal Essential Medium containing 5,uCi of [3H]thymidine for 20min at 37°C. After incubation the DNA was extracted from the washed cells for the determination ofits specificradioactivity, as described by Rizzo et al. (1971) . The rate of DNA synthesis is expressed as c.p.m. incorporated per 1 x 107 cells. The DNA content of nuclei purified from the Novikoff hepatoma cells was measured with diphenylamine (Rizzo et al., 1971) .
Results
Novikoff ascites cells exhibited only minimal dexamethasone-binding activity when assayed immediately after their removal from the intraperitoneal cavity, since the animals were not adrenalectomized. However, the relevant receptor protein is readily detectable in the cytosol fraction after a 2h incubation of the cells in vitro at 37°C in Eagle's Minimum Essential Medium to deplete the cells of endogenous glucocorticoids. Since no further change occurred in the binding capacity of the cytosol of cells derived from untreated or glucocorticoidtreated rats on further incubation, a preincubation period of 2h was selected for all subsequent experiments. Table 1 indicates that after a 1 h incubation of the ascites-tumour cells in medium containing (3H]dexamethasone, approx. 50 % of the radioactivity is located in the nucleus, whereas very little is present in the cytoplasm in a bound form. These data, which are consistent with results on steroid-hormoneresponsive tissues (Jackson & Chalkey, 1974; Wira & Munck, 1974) , are explained by the presently accepted mechanism of intracellular glucocorticoid transport (Kalimi et al., 1973) . According to this mechanism (Thompson & Lipmann, 1974) Fig. 1 . Binding was completed within 120min of incubation at 0°C, and near saturation of the receptor was attained at a dexamethasone concentration of 80nM. An analysis of the data by the method of Scatchard (1949) gave an association constant (Ka) of 1.3x108M-1 with dexamethasone; the concentration of the receptor sites was estimated to be 1.7x 1O-9M. Table 2 shows that these values are very comparable with those reported for normal rat liver and for hepatoma tissue-culture cells.
The data in Table 3 (Baxter & Tomkins, 1970) , lactating mammary glands (Shyamala, 1973) and leukaemic blast cells Generation number Fig. 3 . Changes in the concentration ofthe dexamethasone-bindingprotein (0) and in its nuclear uptake (0) The present results confirm the existence in the rapidly growing Novikoff hepatoma cells of a glucocorticoid-binding protein withproperties similar to the G-protein (dexamethasone-binding protein) in normal liver. Despite near-normal concentrations of a putative G-protein in the Novikoff hepatoma cells the enzyme tyrosine transaminase, which is inducible by cortisol in liver, is neither present in the tumour cells in detectable concentrations, nor is it induced by cortisol (Levitan & Webb, 1970; S. Liu, unpublished work) .
The present study represents the first attempt to analyse the changes in the glucocorticoid-binding protein (more-specifically the G-protein) durinig the early stages of the development in vivo of tumour-cell resistance to glucocorticoids, though many such studies have been carried out in tissue culture (cf. Thompson & Lipmann, 1974) . The principal objective of this study was to select a tumour-cell line that was sensitive to glucocorticoids and to determine the fluctuation in certain parameters of the glucocorticoid-binding protein in response to therapy. Byuse ofthe Novikoffascites cells, which are" growth-inhibited but not killed by glucocorticoids, it was possible to follow alterations occurring in vio, a situation more closely simulating the development of resistance under conditions of cancer chemotherapy.
The results ofthe present investigation demonstrate that significant changes do occur in the concentration of the dexamethasone-binding protein, its K. value and nuclear uptake during the development-of tumour-cell resistance to glucocorticoids. No simple relationship can be proposed between the fluctuations in the parameters studied and the sensitivity to glucocorticoids. In particular, the significance of the fluctuations in the nuclear uptake of the dexamethasone-receptor complex is not apparent, since little is known about the biochemical significance of this parameter. The occurrence of increased amounts of the putative G-protein in generation 1, yet a standard amount of DNA per nucleus in generation 4, suggests that it is not related to clonal selection of a line that is highly polyploid, unless these changes are transient.
The fluctuations observed in the Ka value are indeed ofinterest in view ofevidence ) that more than one molecular species of the G-protein may exist. Differential changes in the relative concentration of two or more binding proteids could account in part for some of the cyclic change observed in other parameters. Marked changes in theratio oftwo isoenzymic forms ofuridine kinase during the early phases of the development of resistance to 5-azacytidine was reported (Keefer et al., 1974 (Keefer et al., , 1975 . Reversible changes in key activating proteins during chemotherapy may be most relevant to the mechanisms underlying the development of irreversible tumour-cell resistance often due to the loss of the activating protein.
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